» Articles » PMID: 37503323

Circadian Rhythm As a Key Player in Cancer Progression As Well As a Therapeutic Target in -positive Advanced Gastric Cancer Treatment

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Jul 28
PMID 37503323
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer is one of the most common cancer types with less than one year prognosis in metastatic disease, which poses a huge disease burden. One of the key players in poor prognosis is human epidermal growth factor receptor 2 (), which also contributes to the pathogenesis of -positive advanced gastric cancer. Trastuzumab is used as first-line chemotherapy that targets the expression of , however, trastuzumab resistance is an inevitable major problem. To overcome this problem, readjustment of the circadian system may play a crucial role, as dysregulation in the expression of circadian clock genes has been observed in tumors. Therefore, pharmacological modulation of clock components can be considered for better efficacy of trastuzumab. In this review, we discuss the association of circadian clock with cancer progression, development, and treatment. Metformin-based chronotherapy can disrupt BMAL1-CLOCK-PER1-HK2 axis, thereby affecting glycolysis oscillation to overcome trastuzumab resistance in HER2-positive advanced gastric cancer.

Citing Articles

Evolving Landscape of HER2-Targeted Therapies for Gastric Cancer Patients.

He L, Liu B, Wang Z, Han Q, Chen H Curr Treat Options Oncol. 2025; .

PMID: 40056280 DOI: 10.1007/s11864-025-01300-0.


The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.

Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R Research (Wash D C). 2025; 8:0612.

PMID: 40046513 PMC: 11880593. DOI: 10.34133/research.0612.


A prognostic model of lung adenocarcinoma constructed based on circadian rhythm genes and its potential clinical significance.

Fu C, Sun L, Feng C, Zhou T, Bi Y Front Oncol. 2025; 15:1464578.

PMID: 40040723 PMC: 11876053. DOI: 10.3389/fonc.2025.1464578.


Jian Pi Hua Tan Fang Reverses Trastuzumab Resistance of HER2-Positive Gastric Cancer Through PI3K/AKT/mTOR Pathway: Integrating Network Pharmacology, Molecular Docking and Experimental Validation.

Hu J, Bu W, Ding Y, Li X, Zhang B, Shen B Immun Inflamm Dis. 2025; 13(2):e70154.

PMID: 39917999 PMC: 11803458. DOI: 10.1002/iid3.70154.


Circadian rhythm disruption and endocrine-related tumors.

Savvidis C, Kallistrou E, Kouroglou E, Dionysopoulou S, Gavriiloglou G, Ragia D World J Clin Oncol. 2024; 15(7):818-834.

PMID: 39071458 PMC: 11271730. DOI: 10.5306/wjco.v15.i7.818.


References
1.
Flores I, Sierra-Fonseca J, Davalos O, Saenz L, Castellanos M, Zavala J . Stress alters the expression of cancer-related genes in the prostate. BMC Cancer. 2017; 17(1):621. PMC: 5583991. DOI: 10.1186/s12885-017-3635-4. View

2.
Panasyuk G, Espeillac C, Chauvin C, Pradelli L, Horie Y, Suzuki A . PPARγ contributes to PKM2 and HK2 expression in fatty liver. Nat Commun. 2012; 3:672. PMC: 3293420. DOI: 10.1038/ncomms1667. View

3.
Mathupala S, Ko Y, Pedersen P . Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene. 2006; 25(34):4777-86. PMC: 3385868. DOI: 10.1038/sj.onc.1209603. View

4.
Xiang S, Coffelt S, Mao L, Yuan L, Cheng Q, Hill S . Period-2: a tumor suppressor gene in breast cancer. J Circadian Rhythms. 2008; 6:4. PMC: 2365929. DOI: 10.1186/1740-3391-6-4. View

5.
Sollars P, Pickard G . The Neurobiology of Circadian Rhythms. Psychiatr Clin North Am. 2015; 38(4):645-65. PMC: 4660252. DOI: 10.1016/j.psc.2015.07.003. View